Volume 7, Number 6—December 2001
Research
The Serologic Response to Cryptosporidium in HIV-Infected Persons: Implications for Epidemiologic Research
Table 2
Case # | Before dx IgG (CD4/days)a | After dx IgG (CD4/days)a | IgG responseb | IgG peak valuec | DIgG responseb |
---|---|---|---|---|---|
1 | 204 (786/102) | 637(500/108) | 433 | 178 | 15 |
2 | 118 (259/100) | 2,376 (186/115) | 2,258 | 463 | 36 |
3 | 977 (96/134) | 12,224(18/216) | 11,247 | 233 | -70 |
4 | 342 (248/138) | 5,724 (440/44) | 5,382 | 263 | -22 |
5 | 1,084 (1,003/907) | 1,309 (M/47) | 225 | 359 | 79 |
6 | 705 (296/71) | 672 (487/369) | -33 | 414 | -80 |
7 | 611 (148/202) | 3,911 (52/293) | 3,300 | 605 | -85 |
8 | 2,200 (39/114) | 1,334 (33/73) | -866 | 973 | -32 |
9 | 891 (159/363) | 2,108 (26/34) | 1,217 | 292 | -35 |
10 | 105 (108/79) | 224 (13/92) | 119 | 187 | -144 |
11 | 102 (435/132) | 102 (472/238) | 0 | 597 | 157 |
aCD4 count and days from cryptosporidiosis diagnosis date.
bDifference in IgG response between a sample taken before and after date of cryptosporidiosis diagnosis.
cAverage of the two controls (CD4 count and sample date were matched to the respective cases).
M = missing data; IgG = immunoglobulin G; dx = diagnosis.
Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.